Biocon Biologics secures market pathway for Denosumab Biosimilars in Europe following settlement with Amgen
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that it has finalized a settlement agreement with Amgen...
